Success Metrics

Clinical Success Rate

66.7%

Based on 2 completed trials

Completion Rate

67%(2/3)

Active Trials

3(43%)

Results Posted

0%(0 trials)

Terminated

1(14%)

Phase Distribution

Ph not_applicable

29%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution2 total trials

N/ANon-phased studies

2(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

66.7%

2 of 3 finished

Non-Completion Rate

33.3%

1 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(3)

Completed(2)

Terminated(1)

Other(1)

Detailed Status

Recruiting3

Completed2

unknown1

Terminated1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

66.7%

Most Advanced

N/A

Trials by Phase

N/A2 (100.0%)

Trials by Status

unknown114%

terminated114%

recruiting343%

completed229%

Recent Activity

3 active trials

Showing 5 of 7

completed

Clinical Trials (7)

Showing 7 of 7 trials

NCT04620538

Volatile Organic Compounds for the Assessment of Liver Disease

Completed

NCT06346054Not Applicable

Molecular Assessment for Gastro-Esophageal Cancer

Recruiting

NCT05427136

Early Pulmonary Dysfunction in Childhood Cancer Patients

Recruiting

NCT03299608

Rapid Analysis of Infections by Spectrometry of Exhaled Breath

Recruiting

NCT04318392

Breath Analysis in Patients With Suspected Sarcoidosis: The VOCs-IS Study

Completed

NCT04514666Not Applicable

VOCs in Kidney and Liver Transplants

Unknown

NCT03275688

NanoSpectrometer Biomarker Discovery and Confirmation Study

Terminated

All 7 trials loaded

Drug Details

Intervention Type: DIAGNOSTIC TEST
Total Trials: 7